Trial intelligence / Profile preview

Cardiovascular Effects of Racemic Epinephrine Pellets in Pediatric Dentistry

NCT04688346Phase 3Completed

Sponsor
University of Washington
Start
Jun 2019
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of HemeRX in dental caries, sponsored by University of Washington. Started Jun 2019; status: completed.

02

Drugs

HemeRX
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT04688346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04688346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call